Hemodialysis is a method for the renal replacement therapy followed by series of acute and chronic complications. Dyselectrolytemia appears in patients undergoing dialysis through mechanisms related to the chronic kidney disease and/or to the dialysis therapy and for this group of patients it is associated with an increase of morbidity and mortality. The dialysate has a standard composition, which can be modified according to the patient's characteristics. During hemodialysis patients are exposed to 18,000-36.000 litres of water/year, and the water purity along with the biochemical composition of the dialysate are essential. The individualization of the dialysis prescription is recommended for each patient and it has an important role in preventing the occurrence of dyselectrolyemia. The individualization of the treatment prescription according to the blood constants of each patient is the prerogative of the nephrologist and the association of the electrolyte imbalances with the patients cardiovascular mortality explains the importance of paying special attention to them.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725007PMC
http://dx.doi.org/10.3892/etm.2020.9534DOI Listing

Publication Analysis

Top Keywords

dyselectrolytemia-management implications
4
implications hemodialysis
4
hemodialysis review
4
review hemodialysis
4
hemodialysis method
4
method renal
4
renal replacement
4
replacement therapy
4
therapy series
4
series acute
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!